Journal article

Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1

D Castiblanco, JA Rudd-Schmidt, T Noori, VR Sutton, YH Hung, TWH Flinsenberg, AW Hodel, ND Young, N Smith, D Bratkovic, H Peters, M Walterfang, JA Trapani, AJ Brennan, I Voskoboinik

Blood | Published : 2022

Abstract

Niemann-Pick disease type C1 (NP-C1) is a rare lysosomal storage disorder resulting from mutations in an endolysosomal cholesterol transporter, NPC1. Despite typically presenting with pronounced neurological manifestations, NP-C1 also resembles long-term congenital immunodeficiencies that arise from impairment of cytotoxic T lymphocyte (CTL) effector function. CTLs kill their targets through exocytosis of the contents of lysosome-like secretory cytotoxic granules (CGs) that store and ultimately release the essential pore-forming protein perforin and proapoptotic serine proteases, granzymes, into the synapse formed between the CTL and target cell. We discovered that NPC1 deficiency increases ..

View full abstract